CV6 Therapeutics Appoints Chris Rivera to Board

17th March 2018 12:58 pm

Posted by cv6-admin

CV6 Therapeutics

Belfast, U.K. – April 19, 2018. CV6 Therapeutics, a drug development company focused on developing novel therapeutics to enhance the effectiveness of current standard of care therapies, announced today the appointment of Chris Riviera to the Board of Directors. “We are pleased to welcome Chris to our Board. Chris brings extensive experience in the pharmaceutical […]